Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Exelixis, Inc. (EXEL)

-NasdaqGS
3.29 Down 0.03(0.90%) Apr 17, 4:00PM EDT
|After Hours : 3.35 Up 0.06 (1.82%) Apr 17, 7:37PM EDT
Get the big picture on all your investments.
Prev Close:3.32
Open:3.28
Bid:N/A
Ask:3.42 x 500
1y Target Est:7.13
Beta:2.29
Earnings Date:May 5 - May 9 (Est.)
Day's Range:3.26 - 3.44
52wk Range:3.02 - 8.41
Volume:2,689,098
Avg Vol (3m):5,447,990
Market Cap:640.28M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
EXELDown 0.90%640.28M
AZNDown 0.06%79.82B
GSKDown 0.59%125.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.51
Quarterly EPS Est (Mar-14) :-0.37
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer in the United States. The company focuses primarily on developing and commercializing COMETRIQ, an inhibitor of multiple receptor tyrosine kinas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback